Skip to main content

July/August 2010, Vol 3, No 4

Regulatory
Accountable Care Organizations in the Era of Healthcare Reform
Read More
Health Policy and Reform
The New Accountable Care Organizations and Medicare Gain-Sharing Program
Kip Piper, MA, FACHE
Read More
Health Policy and Reform
The Impact of Healthcare Reform on Payers’ Products, Provider Reimbursement, and Member Engagement
Sam Muppalla, Robert Capobianco
Read More
Industry Trends
Enhanced Generic Utilization Saved US Healthcare $139.6 Billion in 2009
Dalia Buffery, MA, ABD
Read More
Industry Trends
The Current State of Bundled Payments
Jim Evans
Read More
Business
Expect the Unexpected: A Role for Behavioral Economics in Understanding the Impact of Cost- Sharing on Emergency Department Utilization
Albert Tzeel, MD, MHSA, CPE, FAAPL, Jack Brown, BA
Stakeholder Perspective
by Alberto M. Colombi, MD, MPH
Read More
Clinical
Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study
Anna D’Souza, PhD, Brian L. Meissner, PharmD, PhD, Boxiong Tang, MD, PhD, Scott McKenzie, MD, Catherine T. Piech, MBA
Stakeholder Perspective
Effectiveness of Anti-TNFs in Patients with RA, and Coverage Considerations
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Business
Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis
Rex W. Force, PharmD, Brooke A. Pugmire, PharmD, Vaughn L. Culbertson, PharmD
Stakeholder Perspective
Can We Afford Improved Clinical Outcomes?
by Atheer A. Kaddis, PharmD
Read More

Results 1 - 8 of 8